FTK vs SNDX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
FTK · Flotek Industries$21.67 ▼ 11.55%
SNDX · Syndax Pharmaceuticals$8.72 ▼ 4.49%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- FTK +53.3%
- SNDX -55.9%
Head to head
| Metric | FTK | SNDX |
|---|---|---|
| Price | $21.67 | $8.72 |
| Change today | ▼ 11.55% | ▼ 4.49% |
| Market cap | $786.22M | $785.05M |
| Return, 3 months | -9.4% | -55.4% |
| Return, year to date | +25.8% | -58.5% |
| Return, 1 year | +56.8% | -50.0% |
| P/E (TTM) | 27.8 | – |
| P/B | 5.5 | -45.7 |
| P/E percentile vs own 5y | 85th | 66th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +104.1% | +81.6% |
| Net profit growth (YoY) | -34.6% | +18.6% |
| Gross margin | 23.3% | 92.2% |
| Operating margin | 13.3% | -61.7% |
| Net margin | 8.8% | -72.3% |
| Return on equity | 24.4% | -426.4% |
| Analyst target vs. price | +82.3% | +332.0% |
| Analyst buy share | 100% | 83% |
| RSI (14) | 37 | 28 |
| 30-day volatility | 82.3% | 117.2% |
| Max drawdown, 1 year | -44.2% | -66.0% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- FTK is the largest of the group by market value.
- FTK has returned the most over the past year.
- FTK is growing revenue fastest.
- FTK keeps the most profit per dollar of sales.
- FTK has been the calmest stock over the last 30 days.